Umicore : The underlying trend is to the upside
Entry price | Target | Stop-loss | Potential |
---|
€42.77 |
€46 |
€41.1 |
+7.55% |
---|
Shares in Umicore show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 55% by 2020.
● The group's high margin levels account for strong profits.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
● The tendency within the weekly time frame is positive above the technical support level at 38.73 EUR
Weaknesses● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.56 times its estimated earnings per share for the ongoing year.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.